SUBSCRIBE
SUBSCRIBE

Belharra Therapeutics

NEWS
exteriors of Merck, Biogen and BMS
Deals
Top I&I Deals So Far in 2024
The size of the global immunology market is projected to nearly double by 2032 to a quarter of a trillion dollars. Here are this year’s standout deals in the space.
August 7, 2024
 · 
5 min read
 · 
Mollie Barnes
Map of NextGen Class of 2024/BioSpace
Business
NextGen Class of 2024: Top Life Sciences Startups to Watch This Year
Rapport Therapeutics tops this year’s list with $250 million in Series A and B financing in just six months.
January 3, 2024
 · 
20 min read
 · 
BioSpace Editorial Staff
IN THE PRESS
Press Releases
Belharra Therapeutics Announces Appointment of Sean Buchanan, Ph.D., as Chief Scientific Officer and Retirement of Gary O’Neill, Ph.D.
January 13, 2025
 · 
3 min read
Business
Belharra Therapeutics Announces Broad Collaboration with Genentech to Discover and Develop Novel Medicines Across Multiple Therapeutic Areas
January 4, 2023
 · 
3 min read
Business
Belharra Therapeutics Debuts With $130 Million in Funding
January 4, 2023
 · 
10 min read
AWARDS
  • NextGen Badge - Brighspot Rework_NextGen - Class of 2024.jpg
JOBS